CD8A and myeloid sarcoma: Similarly, enhanced TMEV-specific CD4+ and CD8+ T cell responses in the CNS are associated with decreased IL-10 production in CD11b+Ly6c+ depleted mice [105] and in MS patients a leukocyte disability to produce IL-10 is supposed to foster CNS disease progression [106].